Macular Edema
📧 Sign up to get email alerts when something new happens for Macular Edema.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-04-14EMA Application withdrawn: Skojoy (aflibercept) — Amgen Technology (Ireland) UC
EMA has withdrawn the marketing authorization application for Skojoy (aflibercept) submitted by Amgen Technology (Ireland) UC. The applicati…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Bevacizumab and Retinal Vascular Occlusions [Phase 3]
A Phase 3 trial of bevacizumab for macular edema and retinal vascular occlusion has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Avastin for Post-photocoagulation Macular Edema [Phase 4]
A Phase 4 trial of bevacizumab (Avastin) for macular edema after photocoagulation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-09Clinical Trial Update: Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating trientine hydrochloride to prevent macular edema after cataract surgery in patients with type 2 diabetes mellitus h…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids [Phase 2]
A Phase 2 trial evaluating ranibizumab or steroids for uveitic macular edema has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) [NA]
A pilot trial evaluating reduced-fluence photodynamic therapy with Visudyne plus ranibizumab versus ranibizumab alone for exudative age-rela…